A Columbus pharmaceutical manufacturing and research facility has been ordered to pay a $4,400 fine by the Ohio Environmental Protection Agency after an inspection found that the company violated ...
Hikma Pharmaceuticals USA will invest $1 billion by 2030 to further expand its U.S. manufacturing and R&D capabilities. This new phase of investment -- America Leans on Hikma: Quality Medicines ...
London, 15 May 2025 – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, is today hosting sell-side analysts and investors at its US manufacturing and R&D facility in ...
Hikma abandons medium-term targets CEO Darwazah to step down as chair, focus on strategic turnaround 2026 seen as reset year with increased R&D investments Shares down 16% Feb 26 (Reuters) - British ...
(ShareCast News) - Hikma Pharmaceuticals has agreed the sale of manufacturing facilities in Bedford, Ohio, to Xellia Pharmaceuticals for an undisclosed sum.Hikma bought the assets from Boehringer ...
COLUMBUS, Ohio, Feb. 21, 2024 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today welcomed Dr. Rahul Gupta, Director of the White House Office of ...
London, 28 July 2015 – Hikma Pharmaceuticals PLC ("Hikma" or the "Company") (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), the fast growing multinational pharmaceutical group, today announces that it ...
Hikma has already cut 200 jobs since picking up generics business Roxane Labs from Boehringer Ingelheim, but more layoffs are coming. As CFO Khalid Nabilsi told Reuters, another 200 positions are ...
LONDON (Alliance News) - Hikma Pharmaceuticals PLC said Wednesday that it has agreed to sell manufacturing facilities in Bedford, Ohio that were previously owned by Ben Venue Laboratories Inc to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results